Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-073017
Filing Date
2025-05-15
Accepted
2025-05-15 19:41:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5644
2 EX-99.A ck0001669811-ex99_a.pdf EX-99.A 170585
  Complete submission text file 0000950170-25-073017.txt   242596
Mailing Address 100 PEARL STREET 27TH FLOOR NEW YORK NY 10004
Business Address 100 PEARL STREET 27TH FLOOR NEW YORK NY 10004 2128068806
ALGER ASSOCIATES INC (Filed by) CIK: 0001000264 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G/A

Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Subject) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-85385 | Film No.: 25956565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)